A recent article on the Internet connected Greg Duncan, a successful IBO powered by Quixtar, with All In Energy Drink. It resulted in a rumor that Mr. Duncan was in violation of Rule 6.5 of the Quixtar Rules of Conduct. While it’s true Mr. Duncan is a principal of XS Energy Drink, and is associated with All In Energy Drink, the rumor is false.
The fact is, XS Energy Drinks are marketed to Quixtar for sale exclusively by IBOs and All In Energy Drink is marketed to an entirely different market not in competition with Quixtar or IBOs. The manufacture and sale of All In Energy Drink does not violate either the letter or the spirit of the Rules of Conduct.
Says Mr. Duncan, “The most important question is how this activity affects Quixtar IBOs and their marketing of XS Energy Drinks. The principals of XS Energy Drinks do not want to ever be accused of playing semantics or being misleading. They want to be clear and forthright about their priorities, their focus, and their involvement in the beverage world.
“The principals of XS Energy Drinks are more committed to the immediate and long-term opportunities for XS and IBOs than ever before. They are investing more of their resources to that end than at any other time in the six-year partnership of XS and Quixtar.
“As many IBOs know, the principals of Alticor manufacture for and invest in brands and other entrepreneurial ventures beyond their direct roles with Quixtar/Amway products. Like the principals of Alticor the principals of XS Energy Drinks pursue similar ventures for the purposes of reducing costs and enhancing the effectiveness of products for IBOs and to empower opportunities for IBOs. The positive proof of the effectiveness of such an approach has clearly shown through with not a single penny of increase in XS pricing in nearly six years. Additionally, the XS team has been unparalleled in their generosity to IBOs and IBO events with support staff, product sampling, literature, gear and gifts at absolutely no cost to the IBOs. Such commitment to the product and IBOs will continue to be our utmost priority.”